Markets:

Overview

News

Currencies

International

Treasuries

Geron Corporation - Common Stock (NQ:GERN)

0.9552 -0.1248 (-11.56%)

Delayed Quote Updated: 3:16 PM EST, Nov 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Geron Corporation - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

16 17 Next >

Geron to Participate at Upcoming Investor Conferences in April

April 03, 2024

From Geron Corporation

Via Business Wire

Geron Stock Doubles After Imetelstat Receives FDA Panel Approval

March 20, 2024

Geron stock is up more than 92% after the company's flagship blood cancer therapy received approval from an FDA advisory panel

Via MarketBeat

Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

March 19, 2024

From Geron Corporation

Via Business Wire

Geron Corp. (NASDAQ: GERN) Near Top of Volume Charts in Friday Trading

March 15, 2024

Via Investor Brand Network

Why Nuvei Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗

March 18, 2024

Shares of Nuvei Corp (NASDAQ: NVEI) rose sharply in today’s pre-market trading following a report indicating the company is in buyout talks with Advent International. Nuvei shares jumped 14.1% to...

Via Benzinga

Logitech, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

March 18, 2024

U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining by around 100 points on Monday. Shares of Logitech International S.A. (NASDAQ: LOGI) fell in today’s pre-market...

Via Benzinga

Inflation Squeezes Stocks, Bitcoin Slips To $68,000, While Commodities On Track For Best Week In Months: What's Driving Markets Friday? ↗

March 15, 2024

Wall Street continues to maintain a risk-off sentiment in Friday’s session, echoing the pessimism triggered by Thursday’s unexpectedly high producer inflation figures.

Via Benzinga

Topics Economy

What's Going On With Cancer Focused-Geron Stock On Friday? ↗

March 15, 2024

Geron sees lower share price with high volume. FDA committee votes favorably on imetelstat for transfusion-dependent anemia in adult MDS patients. June 16, 2024, set as FDA target action date....

Via Benzinga

Why Is Geron (GERN) Stock Up 94% Today? ↗

March 15, 2024

Geron stock is on the rise Friday with heavy trading of GERN shares after the company's blood disorder drug got new backing.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 15, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 14, 2024

Via Benzinga

Geron Stock Is Soaring After Hours: What's Going On? ↗

March 14, 2024

Geron shares are soaring in Thursday's after-hours session after the company announced that the U.S. Food and Drug Administration's (FDA) Oncologic drugs advisory committee (ODAC) voted in favor of the...

Via Benzinga

Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS

March 14, 2024

From Geron Corporation

Via Business Wire

Why Geron Stock Is Falling Today ↗

March 12, 2024

Geron shares are trading lower Tuesday after a Reuters report stated FDA staff reviewers raised multiple safety concerns over Geron's anemia drug, imetelstat. According to the report, FDA staff said...

Via Benzinga

FDA Casts Doubts On Geron's Blood Cancer Drug, But Analyst Sees High Probability For Imetelstat's Potential Approval For MDS Anemia Treatment ↗

March 12, 2024

The FDA's review of Geron Corporation's imetelstat application for anemia in lower-risk MDS patients. Expert analysis suggests a favorable AdComm vote and potential full FDA approval by the June 16,...

Via Benzinga

Geron (GERN) Q4 2023 Earnings Call Transcript ↗

February 28, 2024

GERN earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 12, 2024

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

Via Benzinga

Geron Corporation Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

February 28, 2024

From Geron Corporation

Via Business Wire

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 22, 2024

From Geron Corporation

Via Business Wire

MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential ↗

February 22, 2024

MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months.

Via Talk Markets

Geron to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

February 14, 2024

From Geron Corporation

Via Business Wire

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 18, 2024

From Geron Corporation

Via Business Wire

Geron to Participate in the B. Riley Securities Virtual Oncology Conference

January 12, 2024

From Geron Corporation

Via Business Wire

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 21, 2023

From Geron Corporation

Via Business Wire

Geron Announces IMerge Phase 3 Presentations at ASH Highlighting Significant Durability of Transfusion Independence and Breadth of Effect Across MDS Subgroups with Imetelstat in Lower Risk MDS

December 11, 2023

From Geron Corporation

Via Business Wire

Geron Announces Fifty Percent Enrollment in the Phase 3 IMpactMF Clinical Trial Evaluating Imetelstat in Patients with Relapsed/Refractory Myelofibrosis

December 06, 2023

From Geron Corporation

Via Business Wire

Geron Announces Publication in The Lancet of Results from the IMerge Phase 3 Clinical Trial Evaluating Imetelstat in Lower Risk MDS

December 04, 2023

From Geron Corporation

Via Business Wire

Geron Corporation Announces Appointment of Gaurav Aggarwal, M.D., to its Board of Directors

November 28, 2023

From Geron Corporation

Via Business Wire

Are You A Trader Or Investor: Biotech Momentum Is Picking Up ↗

November 20, 2023

ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market.

Via Talk Markets

Topics ETFs

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 16, 2023

From Geron Corporation

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.